ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.

@article{Decker2011ACRAC,
  title={ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.},
  author={Roy H. Decker and Corey J. Langer and Kenneth E. Rosenzweig and Joe Y Chang and Richard M Gewanter and Mark E. Ginsburg and Feng-ming Kong and Brian E. Lally and Gregory M. M. Videtic and Benjamin Movsas},
  journal={American journal of clinical oncology},
  year={2011},
  volume={34 5},
  pages={537-44}
}
Therapeutic options for postoperative adjuvant treatment for patients with non-small cell lung cancer (NSCLC) continue to evolve, and may include postoperative radiotherapy (PORT) and chemotherapy, alone or in combination. The use of platinum-based adjuvant chemotherapy has been demonstrated to confer an improvement in overall survival in patients with completely resected, stage N1 or N2 NSCLC, in several randomized trials and 2 meta-analyses. Consideration may also be given to adjuvant… CONTINUE READING